Richard L. Love
2016
In 2016, Richard L. Love earned a total compensation of $385.8K as Interim Chief Executive Officer and President at CTI BioPharma.
Compensation breakdown
| Option Awards | $266,000 |
|---|---|
| Salary | $90,000 |
| Other | $29,829 |
| Total | $385,829 |
Love received $266K in option awards, accounting for 69% of the total pay in 2016.
Love also received $90K in salary and $29.8K in other compensation.
Rankings
In 2016, Richard L. Love's compensation ranked 12,035th out of 14,075 executives tracked by ExecPay. In other words, Love earned more than 14.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,035 out of 14,075 | 15th |
Division Manufacturing | 4,712 out of 5,486 | 14th |
Major group Chemicals And Allied Products | 1,686 out of 1,900 | 11th |
Industry group Drugs | 1,368 out of 1,543 | 11th |
Industry Pharmaceutical Preparations | 1,054 out of 1,173 | 10th |
Source: SEC filing on March 28, 2017.
Love's colleagues
We found five more compensation records of executives who worked with Richard L. Love at CTI BioPharma in 2016.
2016
James Bianco
CTI BioPharma
Chief Executive Officer
2016
Jack Singer
CTI BioPharma
Chief Scientific Officer
2016
Bruce Seeley
CTI BioPharma
Secretary
2016
Matthew Plunkett
CTI BioPharma
Executive Vice President, Chief Business Officer
2016
Louis Bianco
CTI BioPharma